hydroxychloroquine has been researched along with Chronic Disease in 65 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Hydroxychloroquine (HCQ) is an immunosuppressive lysosomotropic amine that has activity against graft-versus-host disease (GVHD)." | 9.12 | A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. ( Adkins, D; Devine, SM; Dipersio, JF; Fong, T; Goodnough, LT; Graubert, T; Khoury, HJ; Lopez, S; Shenoy, S; Tomasson, M; Trinkaus, K; Vij, R, 2007) |
"The aim of the chronic autoimmune urticaria study and evaluation was to evaluate the efficacy of hydroxychloroquine in patients with chronic idiopathic urticaria." | 9.11 | Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. ( Bonfield, J; Boyle, MJ; Dobson, P; Loewenthal, M; Reeves, GE, 2004) |
"To evaluate retinal toxicity in patients treated with high-dose hydroxychloroquine (HCQ) (Plaquenil, Sanofi Pharmaceuticals) for chronic graft-versus-host disease (GVHD)." | 7.81 | Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease. ( Boyd, S; Easterbrook, M; Hammoudi, DS; Krema, H; Lipton, JH; Navajas, EV; Simpson, ER, 2015) |
"Hydroxychloroquine (HCQ) is a 4-aminoquinoline antimalarial drug used for the treatment of autoimmune diseases." | 6.69 | Hydroxychloroquine for the treatment of chronic graft-versus-host disease. ( Boyer, M; Cahill, R; Chan, KW; Cirenza, E; Frankel, S; Gehan, E; Gilman, AL; Goldman, FD; Mazumder, A; Mogul, A; Morris, C; Schultz, K, 2000) |
"A 2-week treatment with ceftriaxone followed by a 12-week regimen of doxycycline or clarithromycin/hydroxychloroquine did not lead to better cognitive performance compared to a 2-week regimen of ceftriaxone in patients with Lyme disease-attributed persistent symptoms." | 5.30 | Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. ( Berende, A; Evers, AWM; Kessels, RPC; Kullberg, BJ; Ter Hofstede, HJM; van Middendorp, H; Vogelaar, ML; Vos, FJ, 2019) |
"Hydroxychloroquine (HCQ) is an immunosuppressive lysosomotropic amine that has activity against graft-versus-host disease (GVHD)." | 5.12 | A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. ( Adkins, D; Devine, SM; Dipersio, JF; Fong, T; Goodnough, LT; Graubert, T; Khoury, HJ; Lopez, S; Shenoy, S; Tomasson, M; Trinkaus, K; Vij, R, 2007) |
"The aim of the chronic autoimmune urticaria study and evaluation was to evaluate the efficacy of hydroxychloroquine in patients with chronic idiopathic urticaria." | 5.11 | Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. ( Bonfield, J; Boyle, MJ; Dobson, P; Loewenthal, M; Reeves, GE, 2004) |
"A morning standard dose of 250 mcg tetracosactide (Synacthen test) was given in 25 consecutive patients (13 rheumatoid arthritis, 2 psoriatic arthritis, 5 systemic lupus erythematosus, 2 dermatomyositis, 1 systemic sclerosis, 2 temporal arteritis) at the time of relapse upon small reductions (1-2 mg daily) of low prednisolone dose (<7." | 4.12 | Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose. ( Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP, 2022) |
"To evaluate retinal toxicity in patients treated with high-dose hydroxychloroquine (HCQ) (Plaquenil, Sanofi Pharmaceuticals) for chronic graft-versus-host disease (GVHD)." | 3.81 | Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease. ( Boyd, S; Easterbrook, M; Hammoudi, DS; Krema, H; Lipton, JH; Navajas, EV; Simpson, ER, 2015) |
"Chronic ulcerative stomatitis (CUS) is a rare disease of the mucous membranes with characteristics similar to other autoimmune diseases." | 2.82 | Clinical and immunological features of chronic ulcerative stomatitis: A systematic review. ( Palma, VM; Rados, PV; Schroeder, FMM; Visioli, F, 2022) |
"Hydroxychloroquine (HCQ) is a 4-aminoquinoline antimalarial drug used for the treatment of autoimmune diseases." | 2.69 | Hydroxychloroquine for the treatment of chronic graft-versus-host disease. ( Boyer, M; Cahill, R; Chan, KW; Cirenza, E; Frankel, S; Gehan, E; Gilman, AL; Goldman, FD; Mazumder, A; Mogul, A; Morris, C; Schultz, K, 2000) |
"The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic." | 2.66 | Approach to Acute Cardiovascular Complications in COVID-19 Infection. ( Abdalla, M; Anstey, DE; Fried, JA; Givens, RC; Karmpaliotis, D; Kirtane, AJ; Kodali, SK; Kumaraiah, D; Leon, MB; Masoumi, A; Rabbani, LE; Ranard, LS; Sayer, G; Schwartz, A; Takeda, K; Uriel, N, 2020) |
"Chronic ulcerative stomatitis (CUS) is a mucocutaneous disorder which is characterised by persistent oral mucosal ulceration." | 2.47 | Chronic ulcerative stomatitis: a distinct clinical entity? ( Fourie, J; McEachen, SC; van Heerden, WF; van Zyl, A, 2011) |
"Selection of patients with chronic immune thrombocytopenia from the French national prospective cohort of pediatric autoimmune cytopenia OBS'CEREVANCE and VIGICAIRE study, treated by splenectomy, hydroxychloroquine, azathioprine, or rituximab as a first second-line treatment." | 1.62 | Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. ( Abou Chahla, W; Aladjidi, N; Armari-Alla, C; Barlogis, V; Bayart, S; Bertrand, Y; Cheikh, N; Ducassou, S; Fernandes, H; Guitton, C; Kherfellah, D; Laghouati, S; Leblanc, T; Leverger, G; Pasquet, M; Pellier, I; Savel, H; Thiébaut, R; Thomas, C; Vassal, G, 2021) |
"Treatment of chronic Q fever with TET plus QNL appears to be a safe alternative for TET plus HCQ, for example, if TET plus HCQ cannot be tolerated due to side effects." | 1.48 | Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens. ( Bleeker-Rovers, CP; de Regt, MJA; Hoepelman, AIM; Kampschreur, LM; Oosterheert, JJ; van Roeden, SE; Wever, PC, 2018) |
"Hydroxychloroquine was the most common (76%), followed by azathioprine (15%) and methotrexate (13%)." | 1.43 | Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007. ( Elfving, P; Kaipiainen-Seppänen, O; Kautiainen, H; Pohjolainen, T; Puolakka, K; Virta, LJ, 2016) |
"Treatment with Sulfasalazine with and without methotrexate produced good response in 71." | 1.37 | Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up. ( Ganu, AS; Ganu, MA, 2011) |
"Chronic ulcerative stomatitis (CUS) is a recently described condition with specific immunopathologic findings." | 1.35 | Chronic ulcerative stomatitis. ( Solomon, LW, 2008) |
"Hydroxychloroquine alone was given in 4 and was effective in 3." | 1.33 | Chronic inflammation of the vagina: treatment and relationship to autoimmunity. ( Thomson, JC, 2005) |
"Prednisone was used at a starting dose from about 0." | 1.33 | Muscle involvement in sarcoidosis: a retrospective and followup studies. ( Bardin, T; Berenbaum, F; Fayad, F; Lioté, F; Orcel, P, 2006) |
"Chronic ulcerative stomatitis (CUS) is a mucocutaneous disease primarily involving mucosal surfaces, but occasionally may involve the skin." | 1.32 | Chronic ulcerative stomatitis: clinical, histopathologic, and immunopathologic findings. ( Aguirre, A; Costales-Spindler, A; Jividen, GJ; Kumar, V; Neiders, M; Solomon, LW; Zwick, MG, 2003) |
" Hydroxychloroquine, given at a dosage of 200-400 mg/day, led to a complete and long-lasting remission." | 1.30 | Chronic ulcerative stomatitis. ( Kunzelmann, KH; Meurer, M; Plewig, G; Schaller, M; Wollenberg, A; Wörle, B, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (10.77) | 18.7374 |
1990's | 9 (13.85) | 18.2507 |
2000's | 16 (24.62) | 29.6817 |
2010's | 21 (32.31) | 24.3611 |
2020's | 12 (18.46) | 2.80 |
Authors | Studies |
---|---|
Schroeder, FMM | 1 |
Palma, VM | 1 |
Rados, PV | 1 |
Visioli, F | 1 |
Yavropoulou, MP | 1 |
Filippa, MG | 1 |
Panopoulos, S | 1 |
Spanos, E | 1 |
Spanos, G | 1 |
Tektonidou, MG | 1 |
Sfikakis, PP | 1 |
Khan, N | 1 |
Epstein, TG | 1 |
DuBuske, I | 1 |
Strobel, M | 1 |
Bernstein, DI | 1 |
Kaplan, AP | 1 |
Vastarella, M | 1 |
Patrì, A | 1 |
Annunziata, MC | 1 |
Cantelli, M | 1 |
Nappa, P | 1 |
Tasso, M | 1 |
Costa, L | 1 |
Caso, F | 1 |
Fabbrocini, G | 1 |
Ranard, LS | 1 |
Fried, JA | 1 |
Abdalla, M | 1 |
Anstey, DE | 1 |
Givens, RC | 1 |
Kumaraiah, D | 1 |
Kodali, SK | 1 |
Takeda, K | 1 |
Karmpaliotis, D | 1 |
Rabbani, LE | 1 |
Sayer, G | 1 |
Kirtane, AJ | 1 |
Leon, MB | 1 |
Schwartz, A | 1 |
Uriel, N | 1 |
Masoumi, A | 1 |
Györfi, AH | 1 |
Kopp, M | 1 |
May, M | 1 |
Vetter, M | 1 |
Uder, M | 1 |
Kremer, AE | 1 |
Schett, G | 1 |
Harrer, T | 1 |
Distler, JHW | 1 |
Husayn, SS | 1 |
Brown, JD | 1 |
Presley, CL | 1 |
Boghean, K | 1 |
Waller, JD | 1 |
Stoopler, ET | 1 |
Kulkarni, R | 1 |
Alawi, F | 1 |
Sollecito, TP | 1 |
Riou, M | 1 |
Marcot, C | 1 |
Canuet, M | 1 |
Renaud-Picard, B | 1 |
Chatron, E | 1 |
Porzio, M | 1 |
Dégot, T | 1 |
Hirschi, S | 1 |
Metz-Favre, C | 1 |
Kassegne, L | 1 |
Ederle, C | 1 |
Khayath, N | 1 |
Labani, A | 1 |
Leyendecker, P | 1 |
De Blay, F | 1 |
Kessler, R | 1 |
Tejada Cifuentes, F | 1 |
Lloret Callejo, Á | 1 |
Tirado Peláez, MJ | 1 |
Rubio Pulido, O | 1 |
Ruiz-Morote Aragón, M | 1 |
Fernández Urrusuno, R | 1 |
Muñoz Carreras, MI | 1 |
Méndez Esteban, MI | 1 |
Maestre Sánchez, V | 1 |
García Bonilla, A | 1 |
Paredero Dominguez, JM | 1 |
Arroyo Pineda, V | 1 |
Marco Tejón, E | 1 |
Romero Candel, G | 1 |
Fernández Marchante, AI | 1 |
Marco Del Rio, J | 1 |
Ortiz Martín, T | 1 |
López Sánchez, P | 1 |
Ducassou, S | 1 |
Fernandes, H | 1 |
Savel, H | 1 |
Bertrand, Y | 1 |
Leblanc, T | 1 |
Abou Chahla, W | 1 |
Pasquet, M | 1 |
Leverger, G | 1 |
Barlogis, V | 1 |
Thomas, C | 1 |
Bayart, S | 1 |
Pellier, I | 1 |
Armari-Alla, C | 1 |
Guitton, C | 1 |
Cheikh, N | 1 |
Kherfellah, D | 1 |
Vassal, G | 1 |
Thiébaut, R | 1 |
Laghouati, S | 1 |
Aladjidi, N | 1 |
Boonpiyathad, T | 1 |
Sangasapaviliya, A | 1 |
van Roeden, SE | 1 |
Bleeker-Rovers, CP | 1 |
de Regt, MJA | 1 |
Kampschreur, LM | 1 |
Hoepelman, AIM | 1 |
Wever, PC | 1 |
Oosterheert, JJ | 1 |
Iweala, OI | 1 |
Copenhaver, C | 1 |
Wu, EY | 1 |
Moran, TP | 1 |
Merkesdal, S | 1 |
Kirchhoff, T | 1 |
Jablonka, A | 1 |
Schmidt, RE | 1 |
Köhler, L | 1 |
Fardet, L | 1 |
Nazareth, I | 1 |
Petersen, I | 1 |
Berende, A | 1 |
Ter Hofstede, HJM | 1 |
Vos, FJ | 1 |
Vogelaar, ML | 1 |
van Middendorp, H | 1 |
Evers, AWM | 1 |
Kessels, RPC | 1 |
Kullberg, BJ | 1 |
Garrity, ST | 1 |
Jung, JY | 1 |
Zambrowski, O | 1 |
Pichi, F | 1 |
Su, D | 1 |
Arya, M | 1 |
Waheed, NK | 1 |
Duker, JS | 1 |
Chetrit, Y | 1 |
Miserocchi, E | 1 |
Giuffrè, C | 1 |
Kaden, TR | 1 |
Querques, G | 1 |
Souied, EH | 1 |
Freund, KB | 1 |
Sarraf, D | 1 |
Akamine, CM | 1 |
Perez, ML | 1 |
Lee, JH | 1 |
Ing, MB | 1 |
Navajas, EV | 1 |
Krema, H | 1 |
Hammoudi, DS | 1 |
Lipton, JH | 1 |
Simpson, ER | 1 |
Boyd, S | 1 |
Easterbrook, M | 1 |
Elfving, P | 1 |
Puolakka, K | 1 |
Kautiainen, H | 1 |
Virta, LJ | 1 |
Pohjolainen, T | 1 |
Kaipiainen-Seppänen, O | 1 |
Chasset, F | 1 |
Arnaud, L | 1 |
Costedoat-Chalumeau, N | 1 |
Zahr, N | 1 |
Bessis, D | 1 |
Francès, C | 1 |
Steurer, J | 1 |
Ravindran, V | 1 |
Alias, G | 1 |
Solomon, LW | 2 |
Palazzi, C | 1 |
D'Angelo, S | 1 |
Olivieri, I | 1 |
Chopra, A | 1 |
Anuradha, V | 1 |
Lagoo-Joshi, V | 1 |
Kunjir, V | 1 |
Salvi, S | 1 |
Saluja, M | 1 |
Günther, C | 1 |
Meurer, M | 2 |
Stein, A | 1 |
Viehweg, A | 1 |
Lee-Kirsch, MA | 1 |
Cuvelier, GD | 1 |
Kariminia, A | 2 |
Fujii, H | 1 |
Aslanian, S | 1 |
Wall, D | 1 |
Goldman, F | 1 |
Grupp, SA | 3 |
Dunn, SE | 1 |
Krailo, M | 2 |
Shapiro, LH | 1 |
Gilman, A | 1 |
Schultz, KR | 4 |
Pasadhika, S | 1 |
Fishman, GA | 1 |
Choi, D | 1 |
Shahidi, M | 1 |
Lee, HE | 1 |
Ko, JY | 1 |
Lee, CW | 1 |
Rozmus, J | 1 |
Wynne, K | 1 |
Satyanarayana, P | 1 |
Gilman, AL | 4 |
Goldman, FD | 3 |
Sale, GE | 1 |
Krailo, MD | 1 |
Chen, Z | 1 |
Langholz, B | 1 |
Jacobsohn, DA | 1 |
Chan, KW | 2 |
Ryan, RE | 1 |
Kellick, M | 1 |
Neudorf, SM | 1 |
Godder, K | 1 |
Sandler, ES | 1 |
Sahdev, I | 1 |
Sanders, JE | 1 |
Wall, DA | 1 |
Ganu, MA | 1 |
Ganu, AS | 1 |
Fourie, J | 1 |
van Heerden, WF | 1 |
McEachen, SC | 1 |
van Zyl, A | 1 |
Füessl, HS | 1 |
Stiefelhagen, P | 1 |
Aguirre, A | 1 |
Neiders, M | 1 |
Costales-Spindler, A | 1 |
Jividen, GJ | 1 |
Zwick, MG | 1 |
Kumar, V | 2 |
Reeves, GE | 1 |
Boyle, MJ | 1 |
Bonfield, J | 1 |
Dobson, P | 1 |
Loewenthal, M | 1 |
Fritzsche, M | 1 |
Bolaños-Meade, J | 1 |
Zhou, L | 1 |
Hoke, A | 1 |
Corse, A | 1 |
Vogelsang, G | 1 |
Wagner, KR | 1 |
Acharya, N | 1 |
Pineda, R | 2 |
Uy, HS | 2 |
Foster, CS | 2 |
Thomson, JC | 1 |
Healy, B | 1 |
Llewelyn, M | 1 |
Westmoreland, D | 1 |
Lloyd, G | 1 |
Brown, N | 1 |
Fayad, F | 1 |
Lioté, F | 1 |
Berenbaum, F | 1 |
Orcel, P | 1 |
Bardin, T | 1 |
Islam, MN | 1 |
Cohen, DM | 1 |
Ojha, J | 1 |
Stewart, CM | 1 |
Katz, J | 1 |
Bhattacharyya, I | 1 |
Fong, T | 1 |
Trinkaus, K | 1 |
Adkins, D | 1 |
Vij, R | 1 |
Devine, SM | 1 |
Tomasson, M | 1 |
Goodnough, LT | 1 |
Lopez, S | 1 |
Graubert, T | 1 |
Shenoy, S | 1 |
Dipersio, JF | 1 |
Khoury, HJ | 1 |
Mozziconacci, P | 1 |
Hayem, F | 1 |
Guy-Grand, D | 1 |
Callen, JP | 2 |
Nashel, DJ | 1 |
Ulmer, CC | 1 |
Coblyn, JS | 1 |
Taylor, P | 1 |
Alloway, JA | 1 |
Franks, LK | 1 |
Fan, LL | 1 |
Jarrett, P | 1 |
Goodfield, MJ | 1 |
Lewis, JE | 1 |
Beutner, EH | 2 |
Rostami, R | 1 |
Chorzelski, TP | 2 |
Sinha, RN | 1 |
Fraser, WD | 1 |
Casson, IF | 1 |
Wörle, B | 1 |
Wollenberg, A | 1 |
Schaller, M | 1 |
Kunzelmann, KH | 1 |
Plewig, G | 1 |
Shore, JW | 1 |
Polcharoen, W | 1 |
Jakobiec, FA | 1 |
Kossard, S | 1 |
Ma, DD | 1 |
Mogul, A | 1 |
Morris, C | 1 |
Boyer, M | 1 |
Cirenza, E | 1 |
Mazumder, A | 1 |
Gehan, E | 1 |
Cahill, R | 1 |
Frankel, S | 1 |
Schultz, K | 1 |
Parodi, A | 1 |
Schosser, R | 1 |
Guin, J | 1 |
Cardo, PP | 1 |
Maciejowska, E | 1 |
Valeski, JE | 1 |
Spann, CR | 1 |
Klein, JB | 1 |
Kulick, KB | 1 |
Bossa, G | 1 |
Giordano, M | 1 |
Steffen, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
An Impaired Functional Reserve of Adrenal Cortex May Associate With difficult-to Treat RA: Can a Disturbed Cortisol Circadian Rhythm Serve as a Predictor of Difficult-to-treat RA?[NCT05671627] | 50 participants (Anticipated) | Observational | 2022-02-02 | Recruiting | |||
"French National Cohort of Patients With Pediatric-onset of Autoimmune Cytopenia (OBS'CEREVANCE Cohort)"[NCT05937828] | 3,500 participants (Anticipated) | Observational [Patient Registry] | 2010-09-01 | Recruiting | |||
Persistent Lyme Empiric Antibiotic Study Europe. A Prospective, Randomised Study Comparing Two Prolonged Oral Antibiotic Strategies After Initial Intravenous Ceftriaxone Therapy for Patients With Symptoms of Proven or Possible Persistent Lyme Disease[NCT01207739] | Phase 4 | 280 participants (Actual) | Interventional | 2010-09-30 | Completed | ||
Phase III Trial of Hydroxychloroquine + Standard Therapy for Chronic Graft-Versus-Host Disease[NCT00031824] | Phase 3 | 82 participants (Actual) | Interventional | 2002-04-30 | Completed | ||
Hydroxychloroquine Efficacy in Chronic Urticaria[NCT01073852] | 0 participants (Actual) | Interventional | 2011-06-30 | Withdrawn (stopped due to withdrawn, not funded) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for hydroxychloroquine and Chronic Disease
Article | Year |
---|---|
Clinical and immunological features of chronic ulcerative stomatitis: A systematic review.
Topics: Animals; Autoimmune Diseases; Chronic Disease; Female; Fluorescent Antibody Technique, Indirect; Gin | 2022 |
Approach to Acute Cardiovascular Complications in COVID-19 Infection.
Topics: Acute Coronary Syndrome; Anti-Bacterial Agents; Antiviral Agents; Arrhythmias, Cardiac; Azithromycin | 2020 |
Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
Topics: Chronic Disease; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; SARS-CoV-2; United | 2022 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rhe | 2008 |
Chronic ulcerative stomatitis: a distinct clinical entity?
Topics: Adult; Antirheumatic Agents; Chronic Disease; Cyclosporine; Diagnosis, Differential; Female; Gingivi | 2011 |
Chronic ulcerative stomatitis: diagnostic and management challenges--four new cases and review of literature.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dermatologic Agents; Female; Fluorescent Antibody T | 2007 |
Evaluation and therapy of chronic interstitial pneumonitis in children.
Topics: Adrenal Cortex Hormones; Biopsy; Bronchoalveolar Lavage Fluid; Child; Chronic Disease; Clinical Prot | 1994 |
Chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibodies.
Topics: Aged; Antibodies, Antinuclear; Antirheumatic Agents; Binding Sites, Antibody; Biomarkers; Biopsy; Ce | 1996 |
10 trials available for hydroxychloroquine and Chronic Disease
Article | Year |
---|---|
Hydroxychloroquine in the treatment of anti-histamine refractory chronic spontaneous urticaria, randomized single-blinded placebo-controlled trial and an open label comparison study.
Topics: Adult; Anti-Allergic Agents; Chronic Disease; Drug Resistance; Female; Histamine Antagonists; Humans | 2017 |
Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Chronic Disease; Clarithromycin; Cognition; Double-Blind | 2019 |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Dose-Response Relationship, Drug; Doxycyclin | 2016 |
Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.
Topics: Antirheumatic Agents; Arthritis, Infectious; Chikungunya Fever; Chronic Disease; Female; Humans; Hyd | 2017 |
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
Topics: Adolescent; Antibodies; Biomarkers; Bone Marrow Transplantation; CD13 Antigens; Child; Child, Presch | 2010 |
Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cytokines; Double-Blind Method; Female; | 2011 |
Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Double-Blind Method; Female; Graft vs H | 2012 |
Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.
Topics: Adult; Autoimmune Diseases; Chronic Disease; Dermatologic Agents; Female; Humans; Hydroxychloroquine | 2004 |
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Chronic Disease; Disease-Free Survival; Double-Blind Method; Female; Graft vs Host Disease; H | 2007 |
Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Ch | 2000 |
47 other studies available for hydroxychloroquine and Chronic Disease
Article | Year |
---|---|
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rhe | 2022 |
Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Humans; Hydroxychloroquine; Omalizumab; Re | 2022 |
Does hydroxychloroquine work for chronic spontaneous urticaria?
Topics: Chronic Disease; Chronic Urticaria; Humans; Hydroxychloroquine; Urticaria | 2023 |
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Betacoronavirus; Chronic Disease; Coronavirus Infect | 2020 |
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis.
Topics: Chronic Disease; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Recurrence; Sarcoidosis | 2021 |
Novel combination therapy of hydroxychloroquine and topical tacrolimus for chronic ulcerative stomatitis.
Topics: Administration, Topical; Chronic Disease; Combined Modality Therapy; Humans; Hydroxychloroquine; Imm | 2021 |
Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Ch | 2021 |
[Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine].
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Chronic Disease; COVID- | 2021 |
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chronic Disease; Female; Humans; Hydroxychloroqui | 2021 |
Treatment of Chronic Q Fever: Clinical Efficacy and Toxicity of Antibiotic Regimens.
Topics: Aged; Anti-Bacterial Agents; Chronic Disease; Coxiella burnetii; Drug Therapy, Combination; Female; | 2018 |
Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria.
Topics: Acetates; Anti-Inflammatory Agents; Antimalarials; Cetirizine; Chronic Disease; Cyclopropanes; Diphe | 2018 |
Patients With Arthralgia and Anti-Citrullinated Peptide Antibody Positivity on Hydroxychloroquine Therapy: An Update on 2 and 3 Years' Follow-up Data of a Pilot Study.
Topics: Adult; Aged; Anti-Citrullinated Protein Antibodies; Arthralgia; Arthritis, Rheumatoid; Chronic Disea | 2019 |
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease: a population-based cohort study.
Topics: Alzheimer Disease; Antirheumatic Agents; Chloroquine; Chronic Disease; Connective Tissue Diseases; D | 2019 |
Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Topics: Adult; Aged; Antirheumatic Agents; Chronic Disease; Early Diagnosis; Electroretinography; Female; Hu | 2019 |
Q Fever in Southern California: a Case Series of 20 Patients from a VA Medical Center.
Topics: Adult; Aged; Anti-Bacterial Agents; California; Chronic Disease; Doxycycline; Endocarditis, Bacteria | 2019 |
Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Topics: Adult; Aged; Antimalarials; Chronic Disease; Color Vision Defects; Electroretinography; Female; Graf | 2015 |
Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Chronic Disease; Female; Finland; Humans; Hydroxych | 2016 |
The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study.
Topics: Administration, Oral; Adult; Aged; Antimalarials; Chronic Disease; Dose-Response Relationship, Drug; | 2016 |
Chronic ulcerative stomatitis.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Diagnosis, Differential; Female; Gingivitis, Nec | 2008 |
Chikungunya virus aches and pains: an emerging challenge.
Topics: Alphavirus Infections; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chikungunya vi | 2008 |
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
Topics: Adolescent; Aspirin; Biopsy, Needle; Chronic Disease; Disease Progression; Drug Therapy, Combination | 2009 |
Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity.
Topics: Adult; Aged; Antimalarials; Antirheumatic Agents; Chronic Disease; Female; Humans; Hydroxychloroquin | 2010 |
A case of lupus erythematosus panniculitis presenting as combined linear and lipoatrophic skin lesions.
Topics: Adult; Antibodies, Antinuclear; Antimalarials; Chronic Disease; Female; Humans; Hydroxychloroquine; | 2011 |
Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Topics: Adult; Aged; Alphavirus Infections; Antirheumatic Agents; Arthritis, Rheumatoid; Chikungunya Fever; | 2011 |
[Do combinations with hydroxychloroquine help?].
Topics: Anti-Bacterial Agents; Antimalarials; Chronic Disease; Doxycycline; Drug Therapy, Combination; Human | 2012 |
Chronic ulcerative stomatitis: clinical, histopathologic, and immunopathologic findings.
Topics: Adult; Aged; Antibodies, Antinuclear; Blotting, Western; Cell Nucleus; Chronic Disease; Diagnosis, D | 2003 |
Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable?
Topics: Animals; Anti-Bacterial Agents; Borrelia burgdorferi Group; Chronic Disease; Drug Therapy, Combinati | 2005 |
Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease.
Topics: Biopsy; Bone Marrow Transplantation; Chronic Disease; Enzyme Inhibitors; Graft vs Host Disease; Huma | 2005 |
Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis.
Topics: Adult; Antirheumatic Agents; Blepharitis; Chronic Disease; Conjunctivitis; Diagnosis, Differential; | 2005 |
Chronic inflammation of the vagina: treatment and relationship to autoimmunity.
Topics: Adolescent; Adult; Antirheumatic Agents; Autoimmune Diseases; Chronic Disease; Dyspareunia; Endometr | 2005 |
The value of follow-up after acute Q fever infection.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Chronic Disease; Complement Fixation Tests; Coxiella b | 2006 |
Muscle involvement in sarcoidosis: a retrospective and followup studies.
Topics: Adult; Cardiomyopathies; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studie | 2006 |
[Chronic oligoarthritis in children].
Topics: Arthritis, Juvenile; Child; Child, Preschool; Chronic Disease; Female; Glucocorticoids; Humans; Hydr | 1967 |
Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Blood Sedimentation; Chronic Disease; Female; Huma | 1982 |
Systemic lupus erythematosus: important considerations in the adolescent.
Topics: Adolescent; Alopecia; Anxiety; Chronic Disease; Depression; Female; Humans; Hydroxychloroquine; Lupu | 1982 |
Treatment of chronic Lyme arthritis with hydroxychloroquine.
Topics: Adult; Arthritis, Infectious; Chronic Disease; Humans; Hydroxychloroquine; Knee Joint; Male; Radiogr | 1981 |
Hydroxychloroquine in the treatment of chronic erythema nodosum.
Topics: Adult; Chronic Disease; Erythema Nodosum; Female; Humans; Hydroxychloroquine | 1995 |
Hydroxychloroquine and chronic erythema nodosum.
Topics: Chronic Disease; Dermatologic Agents; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Middle A | 1996 |
Long-term management of hypercalcaemia in chronically active sarcoidosis.
Topics: Adult; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Hy | 1997 |
Chronic ulcerative stomatitis.
Topics: Adult; Chronic Disease; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Techniq | 1997 |
Hypertrophic discoid lupus erythematosus of the conjunctiva.
Topics: Biopsy; Blepharitis; Chronic Disease; Conjunctiva; Conjunctivitis; Female; Humans; Hydroxychloroquin | 1999 |
Acral keratotic graft versus host disease simulating warts.
Topics: Bone Marrow Transplantation; Chronic Disease; Diagnosis, Differential; Graft vs Host Disease; Humans | 1999 |
Treatment of chronic GVHD.
Topics: Chronic Disease; Graft vs Host Disease; Humans; Hydroxychloroquine; Randomized Controlled Trials as | 2000 |
Ten cases of chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibody.
Topics: Adult; Aged; Antibodies, Antinuclear; Chronic Disease; Female; Fluorescent Antibody Technique; Gingi | 1991 |
Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Antinuclear; Chronic Disease; DNA, Single-Stranded; Fema | 1988 |
[Use of indomethacin in combination with other antirheumatic drugs in the therapy of chronic inflammatory rheumatism].
Topics: Arthritis, Rheumatoid; Aspirin; Chronic Disease; Dexamethasone; Drug Synergism; Flufenamic Acid; Gol | 1972 |
[Treatment of chronic discoid lupus erythematosus with triamcinolone acetonide using the occlusive dressing technic].
Topics: Adult; Aged; Chronic Disease; Cosmetics; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; M | 1970 |